STOCK TITAN

[Form 4] Alexander & Baldwin, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Insider sale under 10b5-1 plan. An executive officer, Meredith J. Ching, reported the sale of 700 shares of Alexander & Baldwin, Inc. (ALEX) on 10/10/2025 at a weighted average price of $16.7551 per share. After the sale Ms. Ching beneficially owned 146,849 shares directly, plus 213 shares held by a spouse and 781.571 shares held indirectly through the TCESOP. The filing states the sales were executed pursuant to a Rule 10b5-1 trading plan and that shares were sold in multiple transactions at prices ranging from $16.65 to $17.00. The report is a routine Section 16 disclosure showing a planned, pre-arranged disposition rather than an ad hoc trade.

Insider sale under 10b5-1 plan. Un dirigente esecutivo, Meredith J. Ching, ha riferito la vendita di 700 azioni di Alexander & Baldwin, Inc. (ALEX) il 10/10/2025 a un prezzo medio ponderato di $16.7551 per azione. Dopo la vendita la signora Ching deteneva direttamente 146,849 azioni, più 213 azioni detenute dal coniuge e 781.571 azioni detenute indirettamente tramite TCESOP. La pratica riporta che le vendite sono state eseguite ai sensi di un piano di trading 10b5-1 e che le azioni sono state vendute in più operazioni a prezzi che variavano tra $16.65 e $17.00. Il rapporto è una normale dichiarazione della Sezione 16 che mostra una disposizione pianificata e predefinita piuttosto che una operazione ad hoc.

Venta de información privilegiada bajo un plan 10b5-1. Una alta funcionaria, Meredith J. Ching, informó la venta de 700 acciones de Alexander & Baldwin, Inc. (ALEX) el 10/10/2025 a un precio medio ponderado de $16.7551 por acción. Después de la venta, la Sra. Ching poseía directamente 146,849 acciones, además de 213 acciones en poder de su cónyuge y 781.571 acciones poseídas indirectamente a través de TCESOP. La presentación indica que las ventas se realizaron conforme a un plan de trading de la Regla 10b5-1 y que las acciones se vendieron en múltiples transacciones a precios que oscilaban entre $16.65 y $17.00. El informe es una divulgación de la Sección 16 de rutina que muestra una disposición planificada y preestablecida en lugar de una operación ad hoc.

10b5-1 계획에 따른 내부자 매각. 최고경영자 Meredith J. Ching은 Alexander & Baldwin, Inc. (ALEX) 주식 700주를 2025-10-10$16.7551의 가중평균가로 매각했다고 보고했다. 매각 후 Ching은 직접 보유한 주식 146,849주와 배우자 보유 213주, 그리고 TCESOP를 통해 간접 보유한 781.571주를 보유하고 있다. 공시는 매매가 10b5-1 규정에 따른 거래계획에 따라 실시되었으며 주식이 $16.65에서 $17.00 사이의 여러 거래로 매각되었다고 명시한다. 보고서는 사전배치된 처분을 보여주는 일상적인 섹션 16 공시로, 임의의 즉석 거래가 아님을 나타낸다.

Vente d’initié dans le cadre d’un plan 10b5-1. Une cadre dirigeante, Meredith J. Ching, a rapporté la vente de 700 actions de Alexander & Baldwin, Inc. (ALEX) le 10/10/2025 à un prix moyen pondéré de $16.7551 par action. Après la vente, Mme Ching détenait directement 146 849 actions, plus 213 actions détenues par le conjoint et 781,571 actions détenues indirectement par le biais du TCESOP. Le dépôt indique que les ventes ont été exécutées conformément à un plan de trading 10b5-1 et que les actions ont été vendues en plusieurs transactions à des prix allant de $16.65 à $17.00. Le rapport est une divulgation routinière de la section 16 montrant une cession planifiée et préétablie plutôt qu’un commerce ad hoc.

Insider-Verkauf gemäß Plan 10b5-1. Eine leitende Angestellte, Meredith J. Ching, meldete den Verkauf von 700 Aktien von Alexander & Baldwin, Inc. (ALEX) am 10/10/2025 zu einem durchschnittlich gewichteten Preis von $16.7551 pro Aktie. Nach dem Verkauf besaß Frau Ching direkt 146.849 Aktien, zuzüglich 213 Aktien, die ihrem Ehepartner gehören, und 781.571 Aktien, die indirekt über TCESOP gehalten werden. Die Einreichung erklärt, dass die Verkäufe gemäß einem Rule 10b5-1-Handelsplan durchgeführt wurden und dass die Aktien in mehreren Transaktionen zu Preisen zwischen $16.65 und $17.00 verkauft wurden. Der Bericht ist eine routinemäßige Offenlegung gemäß Abschnitt 16, die eine vorgesehene, vorgeplante Veräußerung und kein ad hoc-Handel zeigt.

بيع insider بموجب خطة 10b5-1. أبلغت مسؤولة تنفيذية، ميريديث جيه. تشينغ، عن بيع 700 سهمًا من Alexander & Baldwin, Inc. (ALEX) في 10/10/2025 بسعر متوسط وزني قدره $16.7551 للسهم. بعد البيع كانت السيدة تشين تمتلك مباشرة 146,849 سهمًا، بالإضافة إلى 213 سهمًا مملوكة من قبل الزوج و781.571 سهمًا مملوكًا بشكل غير مباشر من خلال TCESOP. تنص المقدمة على أن المبيعات تمت تنفيذها وفقًا لخطة تداول من النوع 10b5-1 وأن الأسهم بيعت في عدة معاملات بأسعار تراوحت بين $16.65 و $17.00. التقرير هو إفصاح روتيني وفق القسم 16 يبيّن تصرفًا مخططًا مسبقًا بدلاً من تداول عشوائي.

根据 10b5-1 计划的内部人出售。 一位执行官 Meredith J. Ching 报告在 2025/10/10$16.7551 的Alexander & Baldwin, Inc.(ALEX)的700股出售。出售后,Ching 直接持有 146,849 股,加上配偶持有的 213 股以及通过 TCESOP 间接持有的 781.571 股。 filing 显示该等出售是通过规则 10b5-1 交易计划执行,且股票以多笔交易方式出售,价格区间为 $16.65$17.00。该报告是常规的第16条披露,显示为计划好的、预先安排的处置,而非临时交易。

Positive
  • Sale executed under a Rule 10b5-1 trading plan, indicating a pre-arranged disposition
  • Complete Section 16 disclosure including weighted average price and price range
Negative
  • Reporting person reduced direct holdings by 700 shares on 10/10/2025

Insights

Planned disposition disclosed; compliance with Rule 10b5-1 reduces timing concerns.

The sale of 700 shares was reported as executed under a Rule 10b5-1 plan, which indicates the transactions were pre‑arranged and intended to provide an affirmative defense against insider trading allegations. The filing discloses the weighted average sale price of $16.7551 and the intra-range prices from $16.65 to $17.00.

Because the trade is linked to a scheduled plan, the primary dependency for governance review is whether the plan complies with company policy and applicable timing windows; the disclosure here satisfies Section 16 reporting requirements. Investors and compliance teams can note the remaining direct and indirect holdings—146,849 direct shares plus indirect interests—which contextualize the magnitude of the sale relative to total holdings over the near term.

Insider sale under 10b5-1 plan. Un dirigente esecutivo, Meredith J. Ching, ha riferito la vendita di 700 azioni di Alexander & Baldwin, Inc. (ALEX) il 10/10/2025 a un prezzo medio ponderato di $16.7551 per azione. Dopo la vendita la signora Ching deteneva direttamente 146,849 azioni, più 213 azioni detenute dal coniuge e 781.571 azioni detenute indirettamente tramite TCESOP. La pratica riporta che le vendite sono state eseguite ai sensi di un piano di trading 10b5-1 e che le azioni sono state vendute in più operazioni a prezzi che variavano tra $16.65 e $17.00. Il rapporto è una normale dichiarazione della Sezione 16 che mostra una disposizione pianificata e predefinita piuttosto che una operazione ad hoc.

Venta de información privilegiada bajo un plan 10b5-1. Una alta funcionaria, Meredith J. Ching, informó la venta de 700 acciones de Alexander & Baldwin, Inc. (ALEX) el 10/10/2025 a un precio medio ponderado de $16.7551 por acción. Después de la venta, la Sra. Ching poseía directamente 146,849 acciones, además de 213 acciones en poder de su cónyuge y 781.571 acciones poseídas indirectamente a través de TCESOP. La presentación indica que las ventas se realizaron conforme a un plan de trading de la Regla 10b5-1 y que las acciones se vendieron en múltiples transacciones a precios que oscilaban entre $16.65 y $17.00. El informe es una divulgación de la Sección 16 de rutina que muestra una disposición planificada y preestablecida en lugar de una operación ad hoc.

10b5-1 계획에 따른 내부자 매각. 최고경영자 Meredith J. Ching은 Alexander & Baldwin, Inc. (ALEX) 주식 700주를 2025-10-10$16.7551의 가중평균가로 매각했다고 보고했다. 매각 후 Ching은 직접 보유한 주식 146,849주와 배우자 보유 213주, 그리고 TCESOP를 통해 간접 보유한 781.571주를 보유하고 있다. 공시는 매매가 10b5-1 규정에 따른 거래계획에 따라 실시되었으며 주식이 $16.65에서 $17.00 사이의 여러 거래로 매각되었다고 명시한다. 보고서는 사전배치된 처분을 보여주는 일상적인 섹션 16 공시로, 임의의 즉석 거래가 아님을 나타낸다.

Vente d’initié dans le cadre d’un plan 10b5-1. Une cadre dirigeante, Meredith J. Ching, a rapporté la vente de 700 actions de Alexander & Baldwin, Inc. (ALEX) le 10/10/2025 à un prix moyen pondéré de $16.7551 par action. Après la vente, Mme Ching détenait directement 146 849 actions, plus 213 actions détenues par le conjoint et 781,571 actions détenues indirectement par le biais du TCESOP. Le dépôt indique que les ventes ont été exécutées conformément à un plan de trading 10b5-1 et que les actions ont été vendues en plusieurs transactions à des prix allant de $16.65 à $17.00. Le rapport est une divulgation routinière de la section 16 montrant une cession planifiée et préétablie plutôt qu’un commerce ad hoc.

Insider-Verkauf gemäß Plan 10b5-1. Eine leitende Angestellte, Meredith J. Ching, meldete den Verkauf von 700 Aktien von Alexander & Baldwin, Inc. (ALEX) am 10/10/2025 zu einem durchschnittlich gewichteten Preis von $16.7551 pro Aktie. Nach dem Verkauf besaß Frau Ching direkt 146.849 Aktien, zuzüglich 213 Aktien, die ihrem Ehepartner gehören, und 781.571 Aktien, die indirekt über TCESOP gehalten werden. Die Einreichung erklärt, dass die Verkäufe gemäß einem Rule 10b5-1-Handelsplan durchgeführt wurden und dass die Aktien in mehreren Transaktionen zu Preisen zwischen $16.65 und $17.00 verkauft wurden. Der Bericht ist eine routinemäßige Offenlegung gemäß Abschnitt 16, die eine vorgesehene, vorgeplante Veräußerung und kein ad hoc-Handel zeigt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CHING MEREDITH J

(Last) (First) (Middle)
822 BISHOP STREET

(Street)
HONOLULU HI 96813

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alexander & Baldwin, Inc. [ ALEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Exec. VP, External Affairs
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 S(1) 700 D $16.7551(2) 146,849 D
Common Stock 213 I By Spouse
Common Stock 781.571 I By TCESOP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. THE SALES REPORTED IN THIS FORM 4 WERE EFFECTED PURSUANT TO A RULE 10b5-1 TRADING PLAN.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $17.00, inclusive. The reporting person undertakes to provide to Alexander & Baldwin, Inc., any security holder or Alexander & Baldwin, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Meredith J. Ching 10/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Meredith J. Ching report in the Form 4 for ALEX?

The report discloses the sale of 700 ALEX shares on 10/10/2025 under a Rule 10b5-1 plan at a weighted average price of $16.7551.

Were the shares sold under a pre-arranged plan or as an ad hoc trade?

The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan, indicating a pre-arranged sale.

How many ALEX shares does Meredith J. Ching beneficially own after the sale?

After the transaction Ms. Ching beneficially owned 146,849 shares directly, plus 213 held by a spouse and 781.571 indirectly via the TCESOP.

What price range were the shares sold at?

The shares were sold in multiple transactions at prices ranging from $16.65 to $17.00, with a weighted average of $16.7551.

Does this Form 4 indicate any derivative transactions or option exercises?

No. Table II for derivative securities shows no entries; the reported activity relates only to non-derivative common stock sales.
Alexander & Baldwin Inc

NYSE:ALEX

ALEX Rankings

ALEX Latest News

ALEX Latest SEC Filings

ALEX Stock Data

1.23B
72.17M
0.8%
88.11%
1.33%
REIT - Retail
Real Estate Investment Trusts
Link
United States
HONOLULU